Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Venous Thromboembolism Following Major Abdominal Surgery for Cancer: A Guide for the Surgical Intern

Author(s): Christina A. Theochari, Nikoletta A. Theochari*, Konstantinos S. Mylonas, Dimitrios Papaconstantinou, Ilias Giannakodimos, Eleftherios Spartalis, Nikolaos Patelis and Dimitrios Schizas*

Volume 28, Issue 10, 2022

Published on: 15 March, 2022

Page: [787 - 797] Pages: 11

DOI: 10.2174/1381612828666220217140639

Price: $65

Abstract

Background: Venous thromboembolism (VTE) is a term used to compositely describe deep vein thrombosis (DVT) and pulmonary embolism (PE). Overall, the incidence of VTE after major abdominal and pelvic surgery has been reported to be between 10% and 40%.

Objective: The aim of this study is to estimate the incidence of post-operative VTE in patients undergoing major abdominal surgery for cancer, to identify risk factors associated with VTE, and to assess available thromboprophylaxis tools.

Methods: A Medline and Cochrane literature search from database inception until February 1st, 2021 was performed according to the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines.

Results: Thirty-one studies met our eligibility criteria and were included in the current review. In total, 435,492 patients were identified and the overall incidence of VTE was 2.19% (95% CI: 1.82-2.38). Τhe following risk factors were associated with VTE: smoking, advanced age (>70 years), a history of diabetes mellitus, American Society of Anesthesiologists’ (ASA) classification of Physical Health class III or IV, a history of cardiovascular or pulmonary disease, a history of DVT or PE, elevated plasma fibrinogen level, c-reactive protein (CRP) level, cancer stage III or IV, postoperative acute respiratory distress syndrome (ARDS), prolonged postoperative hospital stay, previous steroid use, history of Inflammatory Bowel Disease (IBD), heart failure and neoadjuvant and adjuvant chemotherapy.

Conclusion: VTE remains an important complication after major abdominal surgery for cancer and seems to increase mortality rates.

Keywords: VTE, DVT, PE, abdominal surgery, cancer, prophylaxis.

« Previous Next »
[1]
Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132(3): 936-45.
[http://dx.doi.org/10.1378/chest.06-2993] [PMID: 17573514]
[2]
Gee E. The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89). British J Haematol 2019; 186(5): 792-3.
[http://dx.doi.org/10.1111/bjh.16010]
[3]
Dyer J, Wyke S, Lynch C. Hospital Episode Statistics data analysis of postoperative venous thromboembolus in patients undergoing urological surgery: a review of 126,891 cases. Ann R Coll Surg Engl 2013; 95(1): 65-9.
[http://dx.doi.org/10.1308/003588413X13511609956219] [PMID: 23317732]
[4]
Sutton PA, El-Dhuwaib Y, Dyer J, Guy AJ. The incidence of post operative venous thromboembolism in patients undergoing varicose vein surgery recorded in hospital episode statistics. Ann R Coll Surg Engl 2012; 94(7): 481-3.
[http://dx.doi.org/10.1308/003588412X13171221592096] [PMID: 23031765]
[5]
Theochari NA, Theochari CA, Kokkinidis DG, et al. Venous thromboembolism after esophagectomy for cancer: a systematic review of the literature to evaluate incidence, risk factors, and prophylaxis. Surg Today 2021.(Mar).
[http://dx.doi.org/10.1007/s00595-021-02260-2] [PMID: 33713198]
[6]
Serrano PE, Parpia S, Linkins LA, et al. Venous thromboembolic events following major pelvic and abdominal surgeries for cancer: a prospective cohort study. Ann Surg Oncol 2018; 25(11): 3214-21.
[http://dx.doi.org/10.1245/s10434-018-6671-7] [PMID: 30051364]
[7]
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3)(Suppl.): 338S-400S.
[http://dx.doi.org/10.1378/chest.126.3_suppl.338S] [PMID: 15383478]
[8]
Lee AYY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107(23)(Suppl. 1): I17-21.
[http://dx.doi.org/10.1161/01.CIR.0000078466.72504.AC] [PMID: 12814981]
[9]
Shapiro R, Vogel JD, Kiran RP. Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum 2011; 54(12): 1496-502.
[http://dx.doi.org/10.1097/DCR.0b013e31823302a1] [PMID: 22067177]
[10]
Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 2002; 28(3): 141-4.
[http://dx.doi.org/10.1016/S0305-7372(02)00043-9] [PMID: 12234565]
[11]
National Guideline Centre. Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. In: Natl Inst Heal Care Excell. 2018; 2.
[12]
McNally MP, Burns CJ. Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg 2009; 22(1): 34-40.
[http://dx.doi.org/10.1055/s-0029-1202884] [PMID: 20119554]
[13]
Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg 2005; 241(2): 219-26.
[http://dx.doi.org/10.1097/01.sla.0000151791.93571.70] [PMID: 15650630]
[14]
Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DAJ Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010; 251(2): 344-50.
[http://dx.doi.org/10.1097/SLA.0b013e3181b7fca6] [PMID: 19779324]
[15]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7): e1000097.
[http://dx.doi.org/10.1371/journal.pmed.1000097] [PMID: 19621072]
[16]
Doyle DJ, Goyal A, Bansal P, Garmon EH. American Society of Anesthesiologists Classification Treasure Island (FL) . 2021.
[17]
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25(9): 603-5.
[http://dx.doi.org/10.1007/s10654-010-9491-z] [PMID: 20652370]
[18]
Adiamah A, Ban L, West J, Humes DJ. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study. Dis Esophagus 2020; 33(6): doz079.
[http://dx.doi.org/10.1093/dote/doz079] [PMID: 31617892]
[19]
Ali F, Al-Kindi SG, Blank JJ, Peterson CY, Ludwig KA, Ridolfi TJ. Elevated venous thromboembolism risk following colectomy for IBD is equal to those for colorectal cancer for ninety days after surgery. Dis Colon Rectum 2018; 61(3): 375-81.
[http://dx.doi.org/10.1097/DCR.0000000000001036] [PMID: 29420429]
[20]
Fleming FJ, Kim MJ, Salloum RM, Young KC, Monson JR. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum 2010; 53(10): 1355-60.
[http://dx.doi.org/10.1007/DCR.0b013e3181eb9b0e] [PMID: 20847615]
[21]
Holwell A, McKenzie JL, Holmes M, et al. Venous thromboembolism prevention in patients undergoing colorectal surgery for cancer. ANZ J Surg 2014; 84(4): 284-8.
[http://dx.doi.org/10.1111/ans.12296] [PMID: 23782713]
[22]
Kato F, Takeuchi H, Matsuda S, Kawakubo H, Omori T, Kitagawa Y. Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study. Surg Today 2016; 46(4): 445-52.
[http://dx.doi.org/10.1007/s00595-015-1196-1] [PMID: 26094966]
[23]
Kwon S, Meissner M, Symons R, et al. Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg 2011; 213(5): 596-603.603.e1.
[http://dx.doi.org/10.1016/j.jamcollsurg.2011.07.015] [PMID: 21871823]
[24]
Larsen AC, Frøkjær JB, Fisker RV, et al. Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors. Thromb Res 2015; 135(5): 802-8.
[http://dx.doi.org/10.1016/j.thromres.2015.01.021] [PMID: 25743885]
[25]
Lee FY, Chu W, Chan R, et al. Incidence of deep vein thrombosis after colorectal surgery in a Chinese population. ANZ J Surg 2001; 71(11): 637-40.
[http://dx.doi.org/10.1046/j.0004-8682.2001.02227.x] [PMID: 11736821]
[26]
Mantziari S, Gronnier C, Pasquer A, et al. Incidence and risk factors related to symptomatic venous thromboembolic events after esophagectomy for cancer. Ann Thorac Surg 2016; 102(3): 979-84.
[http://dx.doi.org/10.1016/j.athoracsur.2016.03.093] [PMID: 27262916]
[27]
Martin JT, Mahan AL, Ferraris VA, et al. Identifying esophagectomy patients at risk for predischarge versus postdischarge venous thromboembolism. Ann Thorac Surg 2015; 100(3): 932-8.
[http://dx.doi.org/10.1016/j.athoracsur.2015.04.042] [PMID: 26190389]
[28]
Monn MF, Haut ER, Lau BD, et al. Is venous thromboembolism in colorectal surgery patients preventable or inevitable? One institution’s experience. J Am Coll Surg 2013; 216(3): 395-401.e1.
[http://dx.doi.org/10.1016/j.jamcollsurg.2012.12.004] [PMID: 23312467]
[29]
Rajabi Mashhadi M, Bagheri R, Abdollahi A, et al. The effect of neoadjuvant therapy on early complications of esophageal cancer surgery. Iran J Otorhinolaryngol 2015; 27(81): 279-84.
[http://dx.doi.org/10.22038/ijorl.2015.4247] [PMID: 26788476]
[30]
Bosch DJ, Van Dalfsen QA, Mul VEM, Hospers GAP, Plukker JTM. Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Am J Surg 2014; 208(2): 215-21.
[http://dx.doi.org/10.1016/j.amjsurg.2013.10.031] [PMID: 24534559]
[31]
Moghadamyeghaneh Z, Alizadeh RF, Hanna MH, et al. Post-hospital discharge venous thromboembolism in colorectal surgery. World J Surg 2016; 40(5): 1255-63.
[http://dx.doi.org/10.1007/s00268-015-3361-5] [PMID: 26754074]
[32]
Osaki T, Saito H, Fukumoto Y, et al. Risk and incidence of perioperative deep vein thrombosis in patients undergoing gastric cancer surgery. Surg Today 2018; 48(5): 525-33.
[http://dx.doi.org/10.1007/s00595-017-1617-4] [PMID: 29234961]
[33]
Papaxoinis G, Kamposioras K, Germetaki T, et al. Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy. Acta Oncol 2018; 57(6): 790-8.
[http://dx.doi.org/10.1080/0284186X.2017.1423375] [PMID: 29308947]
[34]
Porteous GH, Neal JM, Slee A, Schmidt H, Low DE. A standardized anesthetic and surgical clinical pathway for esophageal resection: impact on length of stay and major outcomes. Reg Anesth Pain Med 2015; 40(2): 139-49.
[http://dx.doi.org/10.1097/AAP.0000000000000197] [PMID: 25658034]
[35]
Simonneau G, Laporte S, Mismetti P, et al. A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost 2006; 4(8): 1693-700.
[http://dx.doi.org/10.1111/j.1538-7836.2006.02083.x] [PMID: 16796710]
[36]
Song JQ, Xuan LZ, Wu W, Huang JF, Zhong M. Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial. J Thorac Dis 2015; 7(7): 1158-64.
[http://dx.doi.org/10.3978/j.issn.2072-1439.2015.06.15] [PMID: 26380731]
[37]
Song J, Xuan L, Wu W, Shen Y, Tan L, Zhong M. Fondaparinux versus nadroparin for thromboprophylaxis following minimally invasive esophagectomy: A randomized controlled trial. Thromb Res 2018; 166(March): 22-7.
[http://dx.doi.org/10.1016/j.thromres.2018.04.001] [PMID: 29653390]
[38]
Tanaka Y, Yamada A, Hirata S, et al. Efficacy and safety of enoxaparin for prophylaxis of postoperative venous thromboembolism after esophagectomy: a single-center prospective randomized controlled phase II study. Anticancer Res 2019; 39(5): 2615-25.
[http://dx.doi.org/10.21873/anticanres.13385] [PMID: 31092460]
[39]
Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res 2012; 129(5): 568-72.
[http://dx.doi.org/10.1016/j.thromres.2011.07.047] [PMID: 21872295]
[40]
Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg 2011; 35(4): 881-7.
[http://dx.doi.org/10.1007/s00268-011-0957-2] [PMID: 21264469]
[41]
Bouras G, Burns EM, Howell AM, Bottle A, Athanasiou T, Darzi A. Risk of post-discharge venous thromboembolism and associated mortality in general surgery: A population-based cohort study using linked hospital and primary care data in England. PLoS One 2015; 10(12): e0145759.
[http://dx.doi.org/10.1371/journal.pone.0145759] [PMID: 26713434]
[42]
Yoshida N, Baba Y, Miyamoto Y, Iwatsuki M. Prophylaxis of Postoperative Venous Thromboembolism Using Enoxaparin After Esophagectomy : A Prospective Observational Study of Effectiveness and Safety. Ann Surg Oncol 2018; 25: 2434-40.
[http://dx.doi.org/10.1245/s10434-018-6552-0] [PMID: 29876696]
[43]
Chandra R, Melino G, Thomas M, Lawrence MJ, Hunter RA, Moore J. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery? ANZ J Surg 2013; 83(12): 968-72.
[http://dx.doi.org/10.1111/ans.12244] [PMID: 23802729]
[44]
Cooke DT, Calhoun RF, Kuderer V, David EA. A defined esophagectomy perioperative clinical care process can improve outcomes and costs. Am Surg 2017; 83(1): 103-11.
[http://dx.doi.org/10.1177/000313481708300133] [PMID: 28234134]
[45]
Davenport DL, Vargas HD, Kasten MW, Xenos ES. Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb 2012; 18(6): 569-75.
[http://dx.doi.org/10.1177/1076029611433642] [PMID: 22345485]
[46]
Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP. Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008. J Gastrointest Surg 2010; 14(10): 1492-501.
[http://dx.doi.org/10.1007/s11605-010-1328-2] [PMID: 20824375]
[47]
El-Dhuwaib Y, Selvasekar C, Corless DJ, Deakin M, Slavin JP. Venous thromboembolism following colorectal resection. Colorectal Dis 2017; 19(4): 385-94.
[http://dx.doi.org/10.1111/codi.13529] [PMID: 27654996]
[48]
Erem HH, Kiran RP, Remzi FH, Vogel JD. Venous thromboembolism in colorectal surgery: skip SCIP or comply? Tech Coloproctol 2014; 18(8): 719-24.
[http://dx.doi.org/10.1007/s10151-014-1129-9] [PMID: 24562596]
[49]
Wakefield TW, Caprini J, Comerota AJ. Thromboembolic diseases. Curr Probl Surg 2008; 45(12): 844-99.
[http://dx.doi.org/10.1067/j.cpsurg.2008.08.002] [PMID: 18984095]
[50]
Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Clinically significant venous thromboembolism after gynecologic surgery. J Reprod Med 1999; 44(8): 669-73.
[PMID: 10483535]
[51]
de Maistre E, Terriat B, Lesne-Padieu A-S, Abello N, Bouchot O, Steinmetz EF. High incidence of venous thrombosis after surgery for abdominal aortic aneurysm. J Vasc Surg 2009; 49(3): 596-601.
[http://dx.doi.org/10.1016/j.jvs.2008.10.005] [PMID: 19268762]
[52]
MacDonald DRW, Neilly D, Schneider PS, et al. Venous thromboembolism in Hip fracture patients: a subanalysis of the FAITH and HEALTH trials. J Orthop Trauma 2020; 34(Suppl. 3): S70-5.
[http://dx.doi.org/10.1097/BOT.0000000000001939] [PMID: 33027169]
[53]
Elnahal WA, Bassett J, Acharya MR, Chesser T, Ward AJ. Incidence of DVT and PE after surgical reconstruction for pelvic and acetabular fractures: Does routine duplex scanning affect management? Eur J Orthop Surg Traumatol 2021; 31(3): 491-5.
[http://dx.doi.org/10.1007/s00590-020-02795-z] [PMID: 32955697]
[54]
Bertsimas D, Masiakos PT, Mylonas KS, Wiberg H. Prediction of cervical spine injury in young pediatric patients: an optimal trees artificial intelligence approach. J Pediatr Surg 2019; 54(11): 2353-7.
[http://dx.doi.org/10.1016/j.jpedsurg.2019.03.007] [PMID: 30928154]
[55]
Coccolini F, Montori G, Catena F, et al. Splenic trauma: WSES classification and guidelines for adult and pediatric patients. World J Emerg Surg 2017; 12: 40.
[http://dx.doi.org/10.1186/s13017-017-0151-4] [PMID: 28828034]
[56]
Coccolini F, Kobayashi L, Kluger Y, et al. Duodeno-pancreatic and extrahepatic biliary tree trauma: WSES-AAST guidelines. World J Emerg Surg 2019; 14: 56.
[http://dx.doi.org/10.1186/s13017-019-0278-6] [PMID: 31867050]
[57]
Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest In: 2012; 141.(2)(Suppl.): e351S-418S.
[http://dx.doi.org/10.1378/chest.11-2299] [PMID: 22315267]
[58]
Comments on the 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Rev Esp Cardiol (Engl Ed) 2015; 68(1): 10-6.
[http://dx.doi.org/10.1016/j.rec.2014.11.003] [PMID: 25553936]
[59]
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010; 8(11): 2450-7.
[http://dx.doi.org/10.1111/j.1538-7836.2010.04044.x] [PMID: 20738765]
[60]
Golemi I, Salazar Adum JP, Tafur A, Caprini J. Venous thromboembolism prophylaxis using the Caprini score. Dis Mon 2019; 65(8): 249-98.
[http://dx.doi.org/10.1016/j.disamonth.2018.12.005] [PMID: 30638566]
[61]
Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 2012; 10(6): 1019-25.
[http://dx.doi.org/10.1111/j.1538-7836.2012.04735.x] [PMID: 22489957]
[62]
Whiteway A, Burton C. Guideline for the prevention of Venous Thrombo-Embolism (VTE) in adults. Prevention 2008; (December): 2005.
[63]
Wickham N, Gallus AS, Walters BNJ, Wilson A. Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline. Intern Med J 2012; 42(6): 698-708.
[http://dx.doi.org/10.1111/j.1445-5994.2012.02808.x] [PMID: 22697152]
[64]
Venous thromboembolism reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital nice clinical guidelines, No 92 national clinical guideline centre – acute and chronic condition. London 2010.

Rights & Permissions Print Cite
Article Metrics
25
1
© 2024 Bentham Science Publishers | Privacy Policy